Abstract：Objective To analyze the epidemiological features of death comorbid with chronic kidney disease in Ningbo,and to provide reference for chronic kidney disease prevention and control. Methods The information about death comorbid with chronic kidney disease in Ningbo from 2002 to 2017 was collected. The crude mortality,standardized mortality and the proportions of primary death causes were calculated. The annual percentage change（APC）was used to evaluate the trends of the mortality comorbid with chronic kidney disease. Results From 2002 to 2017,the average annual crude mortality rate and standardized mortality rate of Ningbo residents comorbid with chronic kidney disease were 13.31/100 000 and 9.89/100 000,respectively. The crude mortality rate was 14.25/100 000 in males,which was higher than 12.37/100 000 in females（P<0.05）. The crude mortality rate was 14.88/100 000 in urban residents,which was higher than 12.32/100 000 in rural residents（P<0.05）. The crude mortality rates of Ningbo residents comorbid with chronic kidney disease from 2002 to 2017 showed an increasing trend and increased with age（P<0.05）. The primary causes of death comorbid with chronic kidney disease were urogenital diseases,endocrine nutritional and metabolic diseases,circulatory diseases,tumors and infectious diseases or parasitic diseases,accounting for 44.45%,24.32%,13.51%,6.50% and 3.97%,respectively. Conclusion The crude mortality rates of Ningbo residents comorbid with chronic kidney disease from 2002 to 2017 showed an upward trend. Men,the elderly and the urban residents were at high risk. The death comorbid with chronic kidney disease mainly attributed to urogenital disease.
王永, 应焱燕, 崔军, 李辉. 2002—2017年宁波市居民合并慢性肾脏病死亡趋势分析[J]. 预防医学, 2019, 31(8): 774-777.
WANG Yong, YING Yan-yan, CUI Jun, LI Hui. Trend analysis of death comorbid with chronic kidney disease in Ningbo from 2002 to 2017. Preventive Medicine, 2019, 31(8): 774-777.
SCHIEPPATI A,REMUZZI G.Chronic renal diseases as a public health problem:epidemiology,social and economic implications[J]. Kidney Int,2005,68(98):7-10.
KIM H J,FAY M P,FEUER E J,et al.Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med,2000,19(3):335-351.
[12]
National Cancer Institute. Joinpoint trend analysis software version 4.6.0[EB/OL]. (2015-06-23) [2019-05-25]. https://surveillance. cancer.gov/joinpoint.
